Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast

Histopathology

Volumn 46, Issue 1, 2005, Pages 24-30

  Gong, Yun ^a   Sun, X ^a   Huo, L ^b   Wiley, E L ^b   Rao, M S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Angiogenesis; CD44; Cell adhesion molecules; Invasive micropapillary carcinoma of the breast; Microvessel density; Tubular carcinoma

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; UVOMORULIN;

ANGIOGENESIS; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST MICROPAPILLARY CARCINOMA; BREAST PAPILLOMA; CANCER INVASION; CELL ADHESION; CELL DENSITY; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MICROVASCULATURE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RARE DISEASE; STAINING; STATISTICAL SIGNIFICANCE;

ANTIGENS, CD44; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES;

EID: 13244261126     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01981.x     Document Type: Article

References (38)

1. Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum. Pathol. 2001; 32; 583-589.
2. Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod. Pathol. 2001; 14; 836-841.
3. Luna-More S. Gonzalez B, Acedo C, Rodrigo I, Luna C. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol. Res. Pract. 1994; 190; 668-674.
4. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod. Pathol. 1993; 6; 660-662.
5. Amin MB, Tamboli P, Merchant SH et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am. J. Surg. Pathol. 2002; 26; 358-364.
6. Ramalingam P, Middleton LP, Tamboli P, Troncoso P, Silva EG, Ayala AG. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann. Diagn. Pathol. 2003; 7; 112-119.
7. McBoyle MF, Razek HA, Carter JL, Helmer SD. Tubular carcinoma of the breast: an institutional review. Am. Surg. 1997; 63; 639-644; discussion 644-635.
8. Stalsberg H, Hartmann WH. The delimitation of tubular carcinoma of the breast. Hum. Pathol. 2000; 31; 601-607.
9. Sneath RJ, Mangham DC. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 1998; 51; 191-200.
10. Gunthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65; 13-24.
11. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989; 56; 1057-1062.
12. Fujita N, Yaegashi N, Ide Y et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res. 1994; 54; 3922-3928.
13. Asao T, Nakamura J, Shitara Y et al. Loss of standard type of CD44 expression in invaded area as a good indicator of lymphnode metastasis in colorectal carcinoma. Dis. Colon Rectum 2000; 43; 1250-1254; discussion 1254-1255.
14. Carinci F, Stabellini G, Calvitti M et al. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J. Craniofac. Surg. 2002; 13; 85-89.
15. Sato S, Miyauchi M, Takekoshi T et al. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. Oral Oncol 2000; 36; 545-549.
16. Schneider J, Pollan M, Ruibal A et al. Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer. Tumour Biol. 1999; 20; 319-330.
17. Lyzak JS, Yaremko ML, Recant W, Baunoch DA, Joseph L. Role of CD44 in nonpalpable T1a and T1b breast cancer. Hum. Pathol. 1997; 28; 772-778.
18. Koseki S, Aoki T, Ansai S, Hozumi Y, Mitsuhashi Y, Kondo S. An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis. J. Dermatol. 1999; 26; 416-422.
19. Yoshida R., Kimura N, Harada Y, Ohuchi N. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int. J. Oncol. 2001; 18; 513-520.
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl J. Med. 1991; 324; 1-8.
21. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl Cancer Inst. 1974; 52; 413-427.
22. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 1972; 136; 261-276.
23. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407; 249-257.
24. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
25. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29; 577-580.
26. Mikami T, Mitomi H, Hara A et al. Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis- associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer 2000; 89; 733-740.
27. Sun X, Gong Y, Talamonti MS, Rao MS. Expression of cell adhesion molecules. CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod. Pathol 2002; 15; 1333-1338.
28. Petersen JL. Breast carcinomas with unexpected inside out growth pattern. Rotation of polarization associated with angio-invasion. Pathol. Res. Pract 1993: 189; 780 (Abstract).
29. De La Cruz C, Moriya T, Endoh M et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol. Int. 2004; 54; 90-96.
30. Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 2004; 44; 18-23.
31. Sinn HP, Heider KH, Skroch-Angel P et al. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res. Treat. 1995; 36; 307-313.
32. Herrera-Gayol A, Jothy S. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp. Mol. Pathol. 1999; 66; 99-108.
33. Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Kajiwara T. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer. Breast Cancer Res. Treat. 1999; 53; 177-183.
34. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345; 615-619.
35. Ramesh S, Nash J, McCulloch PG. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br. J. Cancer 1999; 81; 1392-1397.
36. Kimura T, Tanaka S, Haruma K et al. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation, and angiogenesis at the deepest invasive portion of colorectal cancer. Int. J. Oncol 2000; 16; 55-64.
37. Kawanishi K, Doki Y, Shiozaki H et al. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Am. J. Clin. Pathol 2000; 113; 266-274.
38. Nagy JA, Brown LF, Senger DR et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta 1989; 948; 305-326.